Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
21.4M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
425K
-
Shares change
-
-591K
-
Total reported value, excl. options
-
$404K
-
Value change
-
-$634K
-
Number of buys
-
8
-
Number of sells
-
-11
-
Price
-
$0.95
Significant Holders of Imunon, Inc. - Common stock, par value $0.01 per share (IMNN) as of Q4 2024
28 filings reported holding IMNN - Imunon, Inc. - Common stock, par value $0.01 per share as of Q4 2024.
Imunon, Inc. - Common stock, par value $0.01 per share (IMNN) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 425K shares
of 21.4M outstanding shares and own 1.99% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (140K shares), BlackRock, Inc. (58.2K shares), VANGUARD GROUP INC (48.8K shares), Royal Bank of Canada (40.1K shares), RENAISSANCE TECHNOLOGIES LLC (33.6K shares), NORTHERN TRUST CORP (21.6K shares), XTX Topco Ltd (21.4K shares), STATE STREET CORP (21.3K shares), HRT FINANCIAL LP (19.2K shares), and CITADEL ADVISORS LLC (12.8K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.